Skip to main content

Table 4 Biometric characteristics and echocardiographic assessments of the 32 patients with MPS IVA with and without valvular thickening

From: Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA

Echocardiographic parameter

Without valvular thickening (n=18)

With valvular thickening (n=14)

p value

Gender (male/female)

10/8

6/8

0.492

Age (years)

8.7 ± 5.4

14.4 ± 7.1

0.015

Height (z score)

-5.00 ± 3.20

-8.92 ± 3.21

0.002

Weight (z score)

-1.83 ± 1.13

-2.63 ± 0.93

0.042

BMI (z score)

0.02 ± 1.06

0.53 ± 1.24

0.219

BSA (m2)

0.70 ± 0.25

0.70 ± 0.08

0.956

LVMI (g/m2.7)

53.9 ± 24.1

80.9 ± 46.6

0.042

LVMI (z score)

0.11 ± 1.86

2.00 ± 2.30

0.015

SF (%) (normal ≧28)

39.3 ± 6.0

43.2 ± 4.6

0.051

RVDd (z score)

1.32 ± 1.35 (n=17)

1.05 ± 2.20 (n=13)

0.683

IVSd (z score)

1.78 ± 1.54

3.89 ± 3.99

0.047

IVSs (z score)

0.40 ± 1.81

1.82 ± 1.63

0.029

LVIDd (z score)

0.44 ± 1.56

0.71 ± 1.51

0.633

LVIDs (z score)

-0.03 ± 1.08

-0.33 ± 1.06

0.441

LVPWd (z score)

0.09 ± 1.03

0.76 ± 1.58

0.159

LVPWs (z score)

-0.82 ± 0.95

0.83 ± 1.20

0.0001

AoD (z score)

2.56 ± 1.47

4.15 ± 1.44

0.005

LAD (z score)

-0.07 ± 0.99

0.58 ± 1.56

0.158

EF

0.70 ± 0.07

0.75 ± 0.05

0.052

With diastolic dysfunction (MV E/A<1)

n=1 (6%)

n=3 (21%)

0.189

MV E/A (normal≧1)

1.41 ± 0.27 (n=12)

1.16 ± 0.26 (n=14)

0.025

TV E/A (normal≧1)

1.30 ± 0.36 (n=11)

1.31 ± 0.32 (n=10)

0.928

  1. MPS mucopolysaccharidosis, BMI body mass index, BSA body surface area, LVMI left ventricular mass index, SF shortening fraction, RVDd right ventricular end diastolic dimension, IVSd interventricular septum thickness in diastole, IVSs interventricular septum thickness in systole, LVIDd left ventricular internal diameter in diastole, LVIDs left ventricular internal diameter in systole, LVPWd left ventricular posterior wall thickness in diastole, LVPWs left ventricular posterior wall thickness in systole, AoD aortic diameter, LAD left atrial dimension, EF ejection fraction, MV mitral valve, E/A ratio between early and late (atrial) ventricular filling velocity, TV tricuspid valve